1. Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma. Issue 1 (December 2017) Authors: Jebali, M.; Elaidi, R.; Brizard, M.; Fouque, J.; Takouchop, C.; Sabatier, B.; Oudard, S.; Medioni, J. Journal: BMC cancer Issue: Volume 17:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Iatrogenic risk factors associated with hospital readmission of elderly patients: A matched case‐control study using a clinical data warehouse. (14th February 2018) Authors: Schwab, C.; Korb‐Savoldelli, V.; Escudie, J. B.; Fernandez, C.; Durieux, P.; Saint‐Jean, O.; Sabatier, B. Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 43:Number 3(2018) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗